Ottawa, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The global regenerative medicine market size was valued at USD 29.42 billion in 2023 and is predicted to surpass around USD 154.05 billion by 2033, according to Precedence Research. The regenerative medicine market is driven by the rising prevalence of various disorders, the rising number of aging people, and the rising need for precision medicines.
Regenerative medicine is the application of biological science, which helps to heal diseases, problems related to aging, and chronic conditions by restoring or replacing lost or damaged cells, tissues, or organs. Regenerative medicine goes beyond disease management. It helps in discovering new therapies that support the body in repairing and restoring itself to a state of well-being. It aims to treat many conditions, including, but not limited to heart and vascular diseases, systemic autoimmune conditions, diabetes, bone metabolic diseases, cancers, neurodegenerative disorders such as Parkinson’s and Alzheimer’s, severe thermal injuries, traumatic spinal cord damage, and congenital anomalies. This medicine is useful in developing personalized therapies. Thus, the rising demand for personalized therapies contributes to the market growth. Moreover, the rising investments in regenerative medicines further propel the market.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/1176
Regenerative Medicine Market Revenue Analysis by Segments:
Regenerative Medicine Market Size, By Product ($ Million), 2019 to 2022
| Product | 2019 | 2020 | 2021 | 2022 |
| Cell Therapy | 5,288.9 | 7,051.7 | 11,577.1 | 13,932.5 |
| Gene Therapy | 739.9 | 993.4 | 1,642.5 | 1,990.5 |
| Tissue Engineering | 2,538.2 | 3,421.6 | 5,679.6 | 6,910.7 |
| Small Molecules & Biologics | 500.4 | 683.5 | 1,148.9 | 1,414.4 |
Regenerative Medicine Market Size, By Application ($ Million), 2019-2022
| Application | 2019 | 2020 | 2021 | 2022 |
| Cardiovascular | 403.5 | 547.2 | 913.7 | 1,118.4 |
| Oncology | 1,088.1 | 1,459.5 | 2,410.6 | 2,918.5 |
| Dermatology | 591.6 | 788.1 | 1,292.5 | 1,553.9 |
| Musculoskeletal | 3,033.8 | 4,053.1 | 6,667.5 | 8,040.1 |
| Wound healing | 2,575.1 | 3,461.0 | 5,727.8 | 6,948.6 |
| Ophthalmology | 496.4 | 658.6 | 1,075.8 | 1,288.2 |
| Neurology | 275.8 | 371.8 | 617.2 | 751.0 |
| Others | 603.0 | 811.1 | 1,343.0 | 1,629.5 |
Regenerative Medicine Market Key Insights
- North America has dominated the market with the highest market share of 48.57% in 2023.
- Asia-Pacific is expected to grow at a CAGR of 23.60% during the forecast period.
- By product, the technetium-99m segment has contributed more than 57.17% of market share in 2023.
- By application, the cancer segment generated the highest market share of 52.65% in 2023.
- By application, the musculoskeletal segment dominated the market in 2023.
Insight Includes Various Objectives
- Find New Customers
- Go-to-Market Strategies
- Competition Analysis
- Opportunity Assessment
- New Product Development
- Plan Finances/ROI Analysis
- Supply Chain Intelligence/Streamline Operations
- Cross-sectional Analysis
- Cross border Intelligence
- Business Model Innovation
- Blue Ocean vs. Red Ocean Strategies
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1176
U.S. Regenerative Medicine Market Size and Forecast 2024 to 2033
The U.S. regenerative medicine market size was accounted for USD 13.44 billion in 2023, and it is predicted to surpass around USD 83.26 billion by 2033, at a remarkable CAGR of 20% from 2024 to 2033.
North America dominated the market in 2023. The North American regenerative medicine market has witnessed rapid growth and is expected to expand rapidly in the near future. Most of the therapies in this aspect are already either in the process of commercializing their products or in the third stage of clinical trials, which indicates the firms’ commitment to commercializing regenerative medicine products. Governments are heavily investing in tissue engineering. Moreover, advances in stem cell therapies and tissue engineering contributed to the regional market expansion.
- In January 2024, The US National Science Foundation has announced two new NSF Regional Innovation Engines, the Piedmont Triad Regenerative Medicine Engine and the North Carolina Sustainable Textiles Innovation Engine.
The market in Asia Pacific is expected to expand at the fastest rate during the forecast period. This is due to the rising number of research activities focusing on developing cheaper treatment methods and stem cell therapies. China is the fastest-growing economy among other countries in the world; however, Japan excels in the biotechnology and pharmaceutical industries. The high rate of incidence of fatal unintentional trauma injuries and the growing aging population further contribute to the market growth.
Scope of Regenerative Medicine Market
| Report Attribute | Key Statistics |
| Market Size in 2024 | USD 35.82 Billion |
| Market Size by 2033 | USD 154.05 Billion |
| Growth Rate from 2024 to 2033 | CAGR of 18% |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Product |
|
| Material |
|
| Application |
|
| End User | Hospitals & Clinics Commercial Industries Government & Academic Research Institutes |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Regenerative Medicine Market Segmentation Analysis
Product Insights
The tissue engineering segment led the regenerative medicine market in 2023. A major subset of regenerative medicine's focus is tissue engineering, which has many uses, such as treating various diseases and injuries, organ replacement, enhancing drug development, and personalized treatments.
Clinical applications include bladder replacement, artificial urethras, skin grown for burn victims, and cartilage grown for knee implants. Tissue engineering is considered a promising area of regenerative medicine that enables the repair or regeneration of diseased or injured tissues by means of scaffolds and cells.
Application Insights
The musculoskeletal segment dominated the market in 2023. Regenerative medicine offers various benefits to the musculoskeletal system and even diseases such as osteoporosis, osteoarthritis, or muscular dystrophy. Its benefits include pain relief, improved quality of life, non-invasiveness, natural repair mechanisms, tissue restoration, and rehabilitation of bones and muscles. Regenerative medicine employs techniques such as Prolotherapy, plasma-rich platelets (PRP), and Visco supplementation. These procedures promote the physiologic processes of the patient’s healing system that minimizes the risks and promotes faster recovery. In addition to pain management and functional restoration, Prolotherapy, PRP, and Visco supplementation are other means employed toward the same goal.
Regenerative Medicine Market Dynamics
Driver
Rising prevalence of chronic diseases and traumatic injuries
With the significant rise in the prevalence of chronic ailments and traumatic injuries, organ transplantation and regenerative therapy procedures have gained immense attention. Due to the increasing incidence of burns and accident-related injuries, the demand for these treatment options is skyrocketing across the globe. Moreover, the rising advancements in stem cell research significantly contribute to the market growth, as it plays a crucial role in generative medicine studies.
- According to WHO, noncommunicable diseases (NCDs) or chronic diseases cause 74% of all deaths across the globe, with an annual estimated number of deaths reaching 41 million.
Restraint
Inefficiencies of process and high costs
Certain operational inefficiencies in tissue engineering and regenerative medicine include cell detachment, cell propagation, and lack of vascularization. Tissues of more than 100–200 μm cannot be implanted due to scaffold over-population. Moreover, research and development in regenerative medicine often require substantial investments in complex technologies and clinical trials. This leads to high production costs. In addition, limited reimbursement policies for regenerative medicine treatments hamper the market growth.
Browse More Insights:
Biologics Market: The global biologics market was estimated at US$ 348.03 billion in 2022 and it is expected to hit over US$ 620.31 billion by 2032 with a noteworthy CAGR of 6% from 2023 to 2032.
Small Molecule Drug Discovery Market: The global small molecule drug discovery market size was exhibited at USD 75.96 billion in 2022 and is projected to hit around USD 163.76 billion by 2032, growing at a CAGR of 7.97% during the forecast period 2023 to 2032.
Oncology Market: The global oncology market size accounted for USD 225.01 billion in 2024 and is expected to reach around USD 668.26 billion by 2034, expanding at a CAGR of 11.5% from 2024 to 2034.
Cardiovascular Drugs Market: The global cardiovascular drugs market size was valued at USD 144.11 billion in 2023 and is expected to reach around USD 207.78 billion by 2033, poised to grow at a compound annual growth rate (CAGR) of 4% over the forecast period 2024 to 2033.
Neurology Market: The global neurology market size was USD 3.34 billion in 2023, accounted for USD 3.60 billion in 2024, and is expected to reach around USD 7.08 billion by 2033, expanding at a CAGR of 7.60% from 2024 to 2033.
Stem Cells Market: The global stem cells market size was USD 15 billion in 2023, accounted for USD 16.73 billion in 2024, and is expected to reach around USD 48.83 billion by 2034, expanding at a CAGR of 11.3% from 2024 to 2034.
Nanotechnology Market: The global nanotechnology market size was estimated at US$ 10 billion in 2022 and it is expected to hit over US$ 38.23 billion by 2032 with a registered CAGR of 14.40% from 2023 to 2032.
Transplantation Market: The global transplantation market size accounted for USD 17.73 billion in 2024 and is predicted to reach around USD 39.19 billion by 2034, expanding at a CAGR of 8% from 2024 to 2034.
Medical Devices Market: The plastic medical devices market size accounted for USD 640.45 billion in 2024 and is expected to reach around USD 1,146.95 billion by 2034, expanding at a CAGR of 6% from 2024 to 2034.
Opportunity
Emergence of novel technologies
Innovative technologies and advances in medical devices aimed at tissue engineering and regenerative medicine have given rise to translational medications. Companies like Bose Electroforce have developed new devices aimed at organ transplantation and regeneration. The application of regenerative medicine techniques has become possible due to advanced surgical equipment. Medical automation technologies have taken the market for regenerative medicine from clinical to commercial stages. Moreover, the development of cutting-edge technologies offers immense opportunities for developing generative treatments.
- In February 2024, researchers at the University of Wisconsin Madison and Vienna University of Technology have made significant breakthroughs in regenerative medicine, including the development of functional human brain tissue and the generation of replacement tissue for injured cartilage.
Regenerative Medicine Market Top Players:
- Integra LifeSciences Corporation
- Aspect Biosystems
- Amgen, Inc.
- Baxter
- Medtronic plc
- AstraZeneca
- Smith & Nephew plc
- MiMedx Group
- Novartis AG
- Shenzhen SibionoGeneTech Co., Ltd.
Recent developments
- In April 2024, Kuraray Co., Ltd. launched PVA hydrogel microcarriers for cell cultures in regenerative medicine, allowing efficient cell detachment and recovery in bioreactors used for mass cell culture.
- In December 2023, Medicine by Design and CCRM announced a strategic alliance to bolster Canada’s globally-leading position in regenerative medicine.
- In October 2023, Bayer opened its first cell therapy manufacturing facility, aiming to advance regenerative medicines globally.
Major Market Segments Covered:
By Product
- Gene Therapies
- Cell Therapies
- Tissue-Engineering
- Small Molecules & Biologics
By Material
- Synthetic material
- Biodegradable synthetic polymers
- Scaffold
- Artificial Vascular Graft
- Materials Hydrogel Material
- Biologically derived material
- Collagen
- Xenogeneic material
- Genetically Engineered Material
- Deoxyribonucleic Acid Transfection Vectors
- Genetically Manipulated Cell
- Three-Dimensional Polymer Technology
- Transgenics
- Fibroblast
- Neural Stem Cell
- Gene-Activated Matrices
- Pharmaceutical
- Biologics
- Small Molecules
By Application
- Wound Care
- Musculoskeletal
- Ophthalmology
- Oncology
- Cardiovascular
- Dermatology
- Neurology
- Others
By End User
- Hospitals & Clinics
- Commercial Industries
- Government & Academic Research Institutes
By Region
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Thailand
- Latin America
- Brazil
- Mexico
- Argentina
- Middle East and Africa (MEA)
- South Africa
- UAE
- Saudi Arabia
- Kuwait
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/1176
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 650 460 3308
Unlocking Market Insights through Data Excellence
The "Precedence Statistics" flexible dashboard is a powerful tool that offers real-time news updates, economic and market forecasts, and customizable reports. It can be configured to support a wide range of analysis styles and strategic planning needs. This tool empowers users to stay informed and make data-driven decisions in various scenarios, making it a valuable asset for businesses and professionals looking to stay ahead in today's dynamic and data-driven world.
To Access our Premium Real-Time Data Intelligence Tool, Visit: http://www.precedencestatistics.com
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Blogs:
https://www.towardshealthcare.com
https://www.towardspackaging.com
https://www.towardsautomotive.com
For Latest Update Follow Us:
